Horizon Pharma plc to Participate in the Cowen and Company 38th Annual Health Care Conference

Horizon Pharma plc to Participate in the Cowen and Company 38th Annual Health Care Conference

02/26/18

DUBLIN, Ireland, Feb. 26, 2018 (GLOBE NEWSWIRE) -- Horizon Pharma plc (NASDAQ:HZNP) today announced that the company will present at the following conference in March:

Cowen and Company 38th Annual Health Care Conference

  • Date:  March 12, 2018
  • Presentation Time:  4:10 p.m. ET
  • Location:  Boston, Mass.

The presentation will be webcast live and may be accessed by visiting Horizon's website at http://ir.horizon-pharma.com.  A replay of the webcast will be available for the event.

About Horizon Pharma plc
Horizon Pharma plc is focused on researching, developing and commercializing innovative medicines that address unmet treatment needs for rare and rheumatic diseases.  By fostering a growing pipeline of medicines in development and exploring all potential uses for currently marketed medicines, we strive to make a powerful difference for patients, their caregivers and physicians.  For us, it’s personal:  by living up to our own potential, we are helping others live up to theirs.  For more information, please visit www.horizonpharma.com.  Follow @HZNPplc on Twitter, like us on Facebook or explore career opportunities on LinkedIn.
                                                                                                                                      
Contacts:

Investors:                                                                            
Tina Ventura
Senior Vice President,
Investor Relations
investor-relations@horizonpharma.com

Ruth Venning
Executive Director,
Investor Relations
investor-relations@horizonpharma.com

U.S. Media:
Geoff Curtis
Senior Vice President,
Corporate Affairs & Chief Communications Officer
media@horizonpharma.com

Ireland Media:
Ray Gordon
Gordon MRM
ray@gordonmrm.ie

Primary Logo

Source: Horizon Pharma plc